Wedemeyer H - Search Results

1

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.

Gömer A, Klöhn M, Jagst M, Nocke MK, Pischke S, Horvatits T, Schulze Zur Wiesch J, Müller T, Hardtke S, Cornberg M, Wedemeyer H, Behrendt P, Steinmann E, Todt D. Gömer A, et al. Among authors: wedemeyer h. Hepatology. 2023 Dec 1;78(6):1882-1895. doi: 10.1097/HEP.0000000000000514. Epub 2023 Jun 20. Hepatology. 2023. PMID: 37334496 Free PMC article.

2

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Among authors: wedemeyer h. Curr Gastroenterol Rep. 2002 Feb;4(1):23-30. doi: 10.1007/s11894-002-0034-y. Curr Gastroenterol Rep. 2002. PMID: 11825538 Review.

3

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

4

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.

Wedemeyer H, Jäckel E, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Hepatology. 2004 May;39(5):1201-3. doi: 10.1002/hep.20221. Hepatology. 2004. PMID: 15122747 Review. No abstract available.

5

Long-term follow-up after successful interferon therapy of acute hepatitis C.

Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Wiegand J, et al. Among authors: wedemeyer h. Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091

6

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

Reiser M, Hinrichsen H, Benhamou Y, Reesink HW, Wedemeyer H, Avendano C, Riba N, Yong CL, Nehmiz G, Steinmann GG. Reiser M, et al. Among authors: wedemeyer h. Hepatology. 2005 Apr;41(4):832-5. doi: 10.1002/hep.20612. Hepatology. 2005. PMID: 15732092 Clinical Trial.

7

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.

Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H. Cornberg M, et al. Among authors: wedemeyer h. J Hepatol. 2006 Feb;44(2):291-301. doi: 10.1016/j.jhep.2005.10.021. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16360972 Clinical Trial.

8

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group. Wiegand J, et al. Among authors: wedemeyer h. Hepatology. 2006 Feb;43(2):250-6. doi: 10.1002/hep.21043. Hepatology. 2006. PMID: 16440367 Clinical Trial.

9

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.

Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H. Volkmann X, et al. Among authors: wedemeyer h. Hepatology. 2006 Jun;43(6):1311-6. doi: 10.1002/hep.21186. Hepatology. 2006. PMID: 16729308

10

Treatment duration in acute hepatitis C: the issue is not solved yet.

Wedemeyer H, Cornberg M, Wiegand J, Manns M. Wedemeyer H, et al. Hepatology. 2006 Oct;44(4):1051; author reply 1051-2. doi: 10.1002/hep.21348. Hepatology. 2006. PMID: 17006944 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

843 results

Search Page

Filters